Effects of Dietary Intake of Soy Protein and Isoflavones on Cardiovascular Disease Risk Factors in High Risk, Middle-Aged Men in Scotland
Miki Sagara, MS,
Tomo Kanda, PhD,
Marina NJelekera, MD,
Takanori Teramoto, MS,
Lesley Armitage, MS,
Nina Birt, MS,
Christopher Birt, MD, PhD and
Yukio Yamori, MD, PhD, FACN
Department of Preventive Nutritional Medicine, Research Institute for Production Development (M.S.)
Graduate School of Human & Environmental Studies, Kyoto University, (T.K., M.N.)
WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases, Kyoto (Y.Y.), Fujicco Co., Ltd., Kobe (T.T.), JAPAN
Wigan and Bolton Health Authority, Directorate of Public Health, Wigan (N.B., C.B.), SCOTLAND, HSMC
Department of Public Health, University of Birmingham, Birmingham (L.A.), ENGLAND

View larger version (14K):
[in a new window]
|
Fig. 1. Effects of the soy-containing diets (Soy) and the placebo diets (Placebo) on systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), non-HDL-C and non-HDL-C to HDL-C ratio. Values are shown as percentage changes from the baselines (|a@) and S.D. There was no significant difference between the two groups in either parameter.
|
|
Copyright © 2004 by the American College of Nutrition.